Cargando…

Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain

Detalles Bibliográficos
Autores principales: Baumann, Brian C., Sargos, Paul, Efstathiou, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759471/
https://www.ncbi.nlm.nih.gov/pubmed/34348106
http://dx.doi.org/10.1016/j.ijrobp.2021.04.048
_version_ 1784852239912796160
author Baumann, Brian C.
Sargos, Paul
Efstathiou, Jason A.
author_facet Baumann, Brian C.
Sargos, Paul
Efstathiou, Jason A.
author_sort Baumann, Brian C.
collection PubMed
description
format Online
Article
Text
id pubmed-9759471
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97594712022-12-19 Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain Baumann, Brian C. Sargos, Paul Efstathiou, Jason A. Int J Radiat Oncol Biol Phys Editorial Published by Elsevier Inc. 2021-09-01 2021-08-01 /pmc/articles/PMC9759471/ /pubmed/34348106 http://dx.doi.org/10.1016/j.ijrobp.2021.04.048 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Baumann, Brian C.
Sargos, Paul
Efstathiou, Jason A.
Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title_full Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title_fullStr Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title_full_unstemmed Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title_short Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
title_sort standard versus hypofractionated radiation therapy for bladder cancer: new insights, but questions remain
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759471/
https://www.ncbi.nlm.nih.gov/pubmed/34348106
http://dx.doi.org/10.1016/j.ijrobp.2021.04.048
work_keys_str_mv AT baumannbrianc standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain
AT sargospaul standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain
AT efstathioujasona standardversushypofractionatedradiationtherapyforbladdercancernewinsightsbutquestionsremain